Researchers used a computational model to compare two types of brain stimulation for Alzheimer's disease. The simulation involved 200 cases with brain activity patterns drawn from a realistic clinical distribution. One group received fixed 40 Hz stimulation, while the other received individualized frequency stimulation based on their specific brain rhythms. The results showed that the personalized approach produced a mean phase-locking value of 0.504 compared to 0.119 for the fixed method. This represents a four-fold advantage for the individualized method. The study also found this advantage held up even when noise levels changed in the model. No safety data were reported because this was a computer simulation rather than a human trial. Readers should note that these findings come from a simulated population and do not prove the treatment works in people. The main takeaway is that this model provides quantitative support for designing future clinical trials that measure individual brain frequencies before treatment. This computational work helps plan next-generation studies but does not yet change current patient care.
Computational model suggests personalized stimulation beats fixed frequency for Alzheimer's
Photo by Nigel Hoare / Unsplash
What this means for you:
This computational model suggests personalized stimulation may be better than fixed frequency for Alzheimer's disease. More on Alzheimer's Disease
Systematic review and meta-analysis of dietary restriction in Alzheimer's mouse models Dietary restrictions show mixed results in Alzheimer's mouse models
· May 1, 2026
Pilot study assesses safety and feasibility of young donor plasma replacement in mild cognitive impairment Twelve patients with early memory loss received young donor blood plasma safely.
medRxiv · Apr 30, 2026
Personalized Feature Statistics framework characterizes genetic variant effects in Alzheimer's Disease across diverse ancestries Genetic risk for Alzheimer's varies by ancestry in new analysis
medRxiv · Apr 30, 2026
Framingham cohort links longitudinal brain atrophy patterns to cognitive decline and AD biomarkers in community-based participants Brain shrinkage patterns predict Alzheimer's risk in older adults
medRxiv · Apr 30, 2026